119 related articles for article (PubMed ID: 18336269)
21. Bone dynamics and inflammation: lessons from rare diseases.
Matsumoto Y; Rottapel R
Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
[TBL] [Abstract][Full Text] [Related]
22. Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages.
Prod'Homme V; Boyer L; Dubois N; Mallavialle A; Munro P; Mouska X; Coste I; Rottapel R; Tartare-Deckert S; Deckert M
J Clin Invest; 2015 Apr; 125(4):1396-400. PubMed ID: 25705883
[TBL] [Abstract][Full Text] [Related]
23. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.
Levaot N; Simoncic PD; Dimitriou ID; Scotter A; La Rose J; Ng AH; Willett TL; Wang CJ; Janmohamed S; Grynpas M; Reichenberger E; Rottapel R
J Clin Invest; 2011 Aug; 121(8):3244-57. PubMed ID: 21765218
[TBL] [Abstract][Full Text] [Related]
24. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
[TBL] [Abstract][Full Text] [Related]
25. Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induce cytokine expression and NF-κB activation.
Chihara K; Chihara Y; Takeuchi K; Sada K
Biochem J; 2022 Feb; 479(4):503-523. PubMed ID: 35129602
[TBL] [Abstract][Full Text] [Related]
26. The adaptor protein 3BP2 binds human CD244 and links this receptor to Vav signaling, ERK activation, and NK cell killing.
Saborit-Villarroya I; Del Valle JM; Romero X; Esplugues E; Lauzurica P; Engel P; Martín M
J Immunol; 2005 Oct; 175(7):4226-35. PubMed ID: 16177062
[TBL] [Abstract][Full Text] [Related]
27. PARsylation-mediated ubiquitylation: lessons from rare hereditary disease Cherubism.
Matsumoto Y; Rottapel R
Trends Mol Med; 2023 May; 29(5):390-405. PubMed ID: 36948987
[TBL] [Abstract][Full Text] [Related]
28. SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis.
Luci C; Vieira E; Bourinet M; Rousseau D; Bonnafous S; Patouraux S; Lefevre L; Larbret F; Prod'homme V; Iannelli A; Tran A; Anty R; Bailly-Maitre B; Deckert M; Gual P
Cell Mol Gastroenterol Hepatol; 2022; 13(1):173-191. PubMed ID: 34411785
[TBL] [Abstract][Full Text] [Related]
29. The 3BP2 adapter protein is required for chemoattractant-mediated neutrophil activation.
Chen G; Dimitriou I; Milne L; Lang KS; Lang PA; Fine N; Ohashi PS; Kubes P; Rottapel R
J Immunol; 2012 Sep; 189(5):2138-50. PubMed ID: 22815290
[TBL] [Abstract][Full Text] [Related]
30. The 3BP2 adapter protein is required for optimal B-cell activation and thymus-independent type 2 humoral response.
Chen G; Dimitriou ID; La Rose J; Ilangumaran S; Yeh WC; Doody G; Turner M; Gommerman J; Rottapel R
Mol Cell Biol; 2007 Apr; 27(8):3109-22. PubMed ID: 17283041
[TBL] [Abstract][Full Text] [Related]
31. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
32. Second-Generation SYK Inhibitor Entospletinib Ameliorates Fully Established Inflammation and Bone Destruction in the Cherubism Mouse Model.
Yoshimoto T; Hayashi T; Kondo T; Kittaka M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2018 Aug; 33(8):1513-1519. PubMed ID: 29669173
[TBL] [Abstract][Full Text] [Related]
33. Regulation of NK cell-mediated cytotoxicity by the adaptor protein 3BP2.
Jevremovic D; Billadeau DD; Schoon RA; Dick CJ; Leibson PJ
J Immunol; 2001 Jun; 166(12):7219-28. PubMed ID: 11390470
[TBL] [Abstract][Full Text] [Related]
34. Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.
Kadlub N; Sessiecq Q; Mandavit M; L'Hermine AC; Badoual C; Galmiche L; Berdal A; Descroix V; Picard A; Coudert AE
Orphanet J Rare Dis; 2018 Sep; 13(1):166. PubMed ID: 30236129
[TBL] [Abstract][Full Text] [Related]
35. Abl-SH3 binding protein 2, 3BP2, interacts with CIN85 and HIP-55.
Le Bras S; Moon C; Foucault I; Breittmayer JP; Deckert M
FEBS Lett; 2007 Mar; 581(5):967-74. PubMed ID: 17306257
[TBL] [Abstract][Full Text] [Related]
36. The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms.
Saborit-Villarroya I; Martinez-Barriocanal A; Oliver-Vila I; Engel P; Sayos J; Martin M
Mol Immunol; 2008 Jul; 45(12):3446-53. PubMed ID: 18479751
[TBL] [Abstract][Full Text] [Related]
37. Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-α-induced inflammation and bone loss.
Yoshitaka T; Ishida S; Mukai T; Kittaka M; Reichenberger EJ; Ueki Y
J Bone Miner Res; 2014; 29(5):1170-82. PubMed ID: 24978678
[TBL] [Abstract][Full Text] [Related]
38. Positive and negative regulation of high affinity IgE receptor signaling by Src homology region 2 domain-containing phosphatase 1.
Nakata K; Yoshimaru T; Suzuki Y; Inoue T; Ra C; Yakura H; Mizuno K
J Immunol; 2008 Oct; 181(8):5414-24. PubMed ID: 18832698
[TBL] [Abstract][Full Text] [Related]
39. Bone marrow transplantation improves autoinflammation and inflammatory bone loss in SH3BP2 knock-in cherubism mice.
Yoshitaka T; Kittaka M; Ishida S; Mizuno N; Mukai T; Ueki Y
Bone; 2015 Feb; 71():201-9. PubMed ID: 25445458
[TBL] [Abstract][Full Text] [Related]
40. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
